Parathyroid Hormone and Metabolic Syndrome in Obese Patients
Author Information
Author(s): Røislien Jo, Van Calster Ben, Hjelmesæth Jøran
Primary Institution: Morbid Obesity Center, Vestfold Hospital Trust, Tønsberg, Norway
Hypothesis
Is parathyroid hormone a mediator between metabolic syndrome and various biomarkers in morbidly obese patients?
Conclusion
The study suggests that parathyroid hormone is a plausible mediator in the association between metabolic syndrome and several biomarkers, particularly in women.
Supporting Evidence
- 68% of the patients had metabolic syndrome.
- PTH and phosphate had significant direct effects on metabolic syndrome.
- The study found significant gender differences in the effects of PTH on metabolic syndrome.
Takeaway
This study looked at very overweight people and found that a hormone called parathyroid hormone might help explain why they have a higher chance of having metabolic syndrome, especially in women.
Methodology
Fasting serum levels of parathyroid hormone, vitamin D, and magnesium were assessed in a cross-sectional study using Bayesian path analysis.
Potential Biases
Potential selection bias due to referral of patients to a tertiary care center.
Limitations
The cross-sectional design limits the ability to establish cause-effect relationships.
Participant Demographics
The study included 1,017 morbidly obese Caucasian individuals, with 68% being women.
Statistical Information
P-Value
0.013
Confidence Interval
95% Credibility Interval [0.15, 0.57]
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website